Literature DB >> 12591050

Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study.

Sally D Parry1, Rosamund Stansfield, Diana Jelley, Wendy Gregory, Elizabeth Phillips, J Roger Barton, Mark R Welfare.   

Abstract

OBJECTIVE: Irritable bowel syndrome (IBS) has been reported to follow infectious diarrhea. Food-borne infections affect 76 million people in the United States and 9.4 million in England per year; of these, only a small percentage of patients see their doctor, and even fewer will have stool culture confirmation. We hypothesized that patients who present to their doctor with gastroenteritis and have positive stool samples may be different from the normal population with regard to their pre-existing bowel symptoms. Our aim was to determine if patients with bacterial gastroenteritis were more likely to have prior IBS, functional dyspepsia, or functional diarrhea, compared with a control population.
METHODS: Between January, 2000 and January, 2001, subjects with stool positive bacterial gastroenteritis and control subjects from the same primary care practice were invited to participate. The main outcome measure was the presence of IBS, functional dyspepsia, or functional diarrhea diagnosed using self-report Rome II modular questionnaires.
RESULTS: A total of 217 people with recent bacterial gastroenteritis and 265 community controls consented to participate in the study. Of these, 89/217 cases and 46/265 controls had one of the functional GI disorders (OR = 3.3; 95% CI = 2.17-5.00). IBS was present in 67 cases (31%) and 26 controls (10%) (OR = 4.1; 95% CI = 2.49-6.72). There was no statistically significant difference in the presence of prior functional dyspepsia or functional diarrhea.
CONCLUSIONS: IBS is more frequent before diagnosis in people with bacterial gastroenteritis presenting to their primary care physician than in community controls. Studies that examine the rate of IBS after bacterial gastroenteritis need to carefully exclude people with prior IBS in a systematic way.

Entities:  

Mesh:

Year:  2003        PMID: 12591050     DOI: 10.1111/j.1572-0241.2003.07242.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  18 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Cognitive behavioural model of irritable bowel syndrome.

Authors:  Francis Creed
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

3.  Deployment-associated functional gastrointestinal disorders: do we know the etiology?

Authors:  Ashok K Tuteja
Journal:  Dig Dis Sci       Date:  2011-11       Impact factor: 3.199

4.  Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.

Authors:  Walter Morales; Ali Rezaie; Gillian Barlow; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2019-05-31       Impact factor: 3.199

Review 5.  Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth.

Authors:  Hyo-Rang Lee; Mark Pimentel
Journal:  Curr Gastroenterol Rep       Date:  2006-08

6.  Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis.

Authors:  William L Hasler; Henry P Parkman; Laura A Wilson; Pankaj J Pasricha; Kenneth L Koch; Thomas L Abell; William J Snape; Gianrico Farrugia; Linda Lee; James Tonascia; Aynur Unalp-Arida; Frank Hamilton
Journal:  Am J Gastroenterol       Date:  2010-06-29       Impact factor: 10.864

7.  Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS.

Authors:  Mark Pimentel; Walter Morales; Sam-Ryong Jee; Kimberly Low; Laura Hwang; Venkata Pokkunuri; Jim Mirocha; Jeffrey Conklin; Christopher Chang
Journal:  Dig Dis Sci       Date:  2011-01-11       Impact factor: 3.199

8.  Henoch-Schonlein purpura leads to functional gastrointestinal disorders.

Authors:  Miguel Saps; Gati Dhroove; Ashish Chogle
Journal:  Dig Dis Sci       Date:  2010-12-04       Impact factor: 3.199

9.  Irritable Bowel Syndrome: Bacterial Overgrowth--What's Known and What to Do.

Authors:  Mark Pimentel; Sheila Lezcano
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

10.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.